费里纳米复合体为癌症免疫治疗提供了"三只鸟用一块石头"的战略
Wenyue Gao1, Xinyue Yang1, Tianshu Miao1
1Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, The Tianjin Key Laboratory of Biomaterials, Institute of Biomedical Engineering, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin 300192, China.
ACS applied materials & interfaces
|November 12, 2025
概括
这项研究引入了一种用于癌症免疫治疗的新型纳米复合物,增强瘤细胞死亡和免疫反应. 这种方法有选择地准瘤细胞,并在瘤微环境中重新编程免疫细胞,以提高治疗效率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 瘤微环境 (TME) 是免疫抑制的,阻碍了有效的癌症免疫疗法.
- 由于对瘤和免疫细胞的非目标影响,目前的策略面临挑战.
研究的目的:
- 开发一种费里丁-蛋白纳米复合物 (IL@FA NPs) 用于瘤和免疫细胞的双重向.
- 为了增强ferroptosis诱导的瘤细胞死亡和调节TME内的免疫细胞活性.
主要方法:
- 封装光敏剂IR820和脂酸 (LA) 在费里-蛋白纳米复合物 (IL@FA NP) 中.
- 利用激光照射触发IR820和LA释放,诱导铁亡和反应性氧物种 (ROS) 生产.
- 评估IL@FANP对瘤细胞死亡,树突细胞 (DC) 成熟和瘤相关巨细胞 (TAM) 再极化 (M2到M1) 的影响.
主要成果:
- 在激光照射后,IL@FA NPs在瘤细胞中选择性诱导铁亡.
- 铁灭菌诱导的免疫细胞死亡 (ICD) 促进了DC成熟和CD8+T细胞激活.
- 激光激活的IL@FA NPs通过ROS生产促进了TAM的DC成熟和M2到M1再极化.
- 实现了有效的瘤生长抑制,没有观察到毒性.
结论:
- IL@FA NPs为癌症免疫治疗提供了一个有前途的"三只鸟用一块石头"战略.
- 这种方法协同增强瘤细胞铁,DC成熟和TAM再极化.
- 这种双重向策略有可能通过克服TME介导的免疫抑制来提高癌症免疫疗法的疗效.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939


